Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

Stock factor profile

Remus Pharmaceuticals Ltd

REMUS · Healthcare · Pharmaceuticals & Biotechnology

Develops and sells pharmaceutical and healthcare products. Revenue comes from B2B sales, distribution, and retail channels. Focuses on quality, compliance, and research. Operates manufacturing-led pharmaceutical model.

Last price₹880.00
1 day+0.0%
1 month+15.03%
Model ratingLocked
Data as of03 Sep 2026

Performance

Price history

Equity review factors

Factor profile

Factor scores are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags and screen results for Remus Pharmaceuticals Ltd are part of the Wright portfolio review.

Run your free portfolio review

Fundamental snapshot

Fundamentals at a glance

Market cap896
P/E ratio18.9
Factor betaLocked
VolatilityLocked
Model scoreLocked
Screen passLocked

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.